Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MIAMI BEACH, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS), an industry leader and provider of premium body contouring procedures,...
-
NEW YORK, May 27, 2026 (GLOBE NEWSWIRE) -- At the end of the settlement date of May 15, 2026, short interest in 3,727 Nasdaq Global MarketSM securities totaled 17,000,786,423 shares compared with...
-
Business Highlights: Full year revenue surges 34% year-over-year to recent record of $299.2 million12-month backlog expands nearly 40% year-over-year to approximately $280 million Company to host...
-
Total Revenues of $159.4M, up 11% year-over-year Subscription Revenues of $140.9M, up 12% year-over-yearGAAP Operating Margin of 13%, up 1,400 basis points year-over-yearNon-GAAP Operating Margin of...
-
AUSTIN, Texas, May 27, 2026 (GLOBE NEWSWIRE) -- Digital Realty (NYSE: DLR), the world’s largest cloud- and carrier-neutral data center platform, today announced the release of its 2025 Impact...
-
Appointments enhance commercialization readiness as Zentalis advances registrational program for azenosertib in Cyclin-E1 positive platinum-resistant ovarian cancer SAN DIEGO, May 27, 2026 (GLOBE...
-
CAMBRIDGE, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies...
-
NEW YORK, May 27, 2026 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE: SLG), Manhattan’s largest office landlord, today announced that it has closed on the sale of a 49.0% joint venture interest in...
-
BERKELEY, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel...
-
SEATTLE, May 27, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will...